Etalpha


Indications and Reactions:

Role Indications Reactions
Secondary
Myelodysplastic Syndrome 75.0%
Hypertension 25.0%
Gastrointestinal Haemorrhage 33.3%
Melaena 33.3%
Pneumonitis 33.3%
Concomitant
Product Used For Unknown Indication 64.6%
Drug Use For Unknown Indication 8.2%
Renal Failure Chronic 4.6%
Hypertension 3.6%
Hyperparathyroidism Secondary 2.8%
Renal Transplant 2.0%
Essential Hypertension 1.4%
Hypercholesterolaemia 1.4%
Hyperparathyroidism 1.2%
Osteoporosis 1.0%
Scan With Contrast 1.0%
Sleep Disorder 1.0%
Wegener's Granulomatosis 1.0%
Hypovitaminosis 1.0%
Vitamin D Deficiency 1.0%
Diuretic Therapy 0.9%
Tremor 0.9%
Asthma 0.8%
Pain 0.8%
Prophylaxis 0.8%
Rhabdomyolysis 13.2%
Nephrogenic Systemic Fibrosis 11.3%
Blood Parathyroid Hormone Decreased 8.5%
Dyspnoea 8.5%
Peritonitis 5.7%
Renal Impairment 5.7%
Pyrexia 4.7%
Vomiting 4.7%
Lung Infiltration 3.8%
Skin Hypertrophy 3.8%
Skin Induration 3.8%
Tooth Disorder 3.8%
Anaemia 2.8%
Atrial Fibrillation 2.8%
Nausea 2.8%
Shunt Occlusion 2.8%
Staphylococcal Infection 2.8%
Syncope 2.8%
Tongue Neoplasm Malignant Stage Unspecified 2.8%
Ventricular Extrasystoles 2.8%

Drug Data